Literature DB >> 19669342

Iodized oil accumulation in the hypovascular tumor portion of early-stage hepatocellular carcinoma after ultraselective transcatheter arterial chemoembolization.

Shiro Miyayama1, Osamu Matsui, Masashi Yamashiro, Yasuji Ryu, Harumi Takata, Taro Takeda, Hiroyuki Aburano, Noriaki Shigenari.   

Abstract

PURPOSE: We evaluated iodized oil accumulation in the hypovascular portion of early-stage hepatocellular carcinoma (HCC) after ultraselective transcatheter arterial embolization (TACE).
MATERIALS AND METHODS: Forty-seven HCC lesions with hypovascular portions were treated by TACE at the distal level of the sub-subsegmental artery of the liver. Portal blood in the hypovascular portion was classed in two grades by computed tomography (CT) during arterial portography: decreased and preserved. Iodized oil accumulation was classed into three grades on CT obtained 1 week after TACE: (1) dense accumulation in the almost entire tumor, including the hypovascular portion (grade 2); (2) dense accumulation in hypervascular portions but sparse accumulation in hypovascular portion (grade 1); and (3) sparse accumulation or no accumulation (grade 0). Findings on serial follow-up CT images were also analyzed.
RESULTS: Portal blood in the hypovascular portion was decreased in 32 lesions, and preserved in 15 lesions. On CT 1 week after TACE, 32 tumors (68.1%)-23 with decreased portal blood and 9 with preserved portal blood-were classed as grade 2. Twelve tumors (25.5%), six with decreased portal blood and six with preserved portal blood, were classed as grade 1. Three tumors (6.4%) with decreased portal blood were classed into grade 0. In total, 25 tumors (53.2%), 22 in grade 2 and 3 in grade 1, were well controlled by ultraselective TACE during the mean follow-up of 15.8 months.
CONCLUSIONS: Iodized oil accumulation and retention in the hypovascular portion of early-stage HCC was frequently observed after ultraselective TACE, mainly in the hypovascular portion with decreased portal blood.

Entities:  

Year:  2007        PMID: 19669342      PMCID: PMC2717545          DOI: 10.1007/s12072-007-9030-5

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  19 in total

Review 1.  Radiofrequency ablation of the liver: current status.

Authors:  J P McGhana; G D Dodd
Journal:  AJR Am J Roentgenol       Date:  2001-01       Impact factor: 3.959

2.  Selective necrosis of encapsulated malignant lesion within atypical adenomatous hyperplasia of the liver following transarterial embolization. A report of two autopsy cases.

Authors:  K Ueda; K Saito; T Terada; Y Nakanuma
Journal:  J Clin Gastroenterol       Date:  1991-12       Impact factor: 3.062

3.  Arterial blood supply to the posterior aspect of segment IV of the liver from the caudate branch: demonstration at CT after iodized oil injection.

Authors:  Shiro Miyayama; Osamu Matsui; Keiichi Taki; Tetsuya Minami; Yasuji Ryu; Chiharu Ito; Koichi Nakamura; Dai Inoue; Shigeyuki Takamatsu
Journal:  Radiology       Date:  2005-10-26       Impact factor: 11.105

4.  Iodized oil in the portal vein after arterial embolization.

Authors:  H Nakamura; T Hashimoto; H Oi; S Sawada
Journal:  Radiology       Date:  1988-05       Impact factor: 11.105

5.  Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium.

Authors:  M Hayashi; O Matsui; K Ueda; Y Kawamori; M Kadoya; J Yoshikawa; T Gabata; T Takashima; A Nonomura; Y Nakanuma
Journal:  AJR Am J Roentgenol       Date:  1999-04       Impact factor: 3.959

6.  Hepatic artery embolization in 120 patients with unresectable hepatoma.

Authors:  R Yamada; M Sato; M Kawabata; H Nakatsuka; K Nakamura; S Takashima
Journal:  Radiology       Date:  1983-08       Impact factor: 11.105

7.  Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma.

Authors:  J M Llovet; R Vilana; C Brú; L Bianchi; J M Salmeron; L Boix; S Ganau; M Sala; M Pagès; C Ayuso; M Solé; J Rodés; J Bruix
Journal:  Hepatology       Date:  2001-05       Impact factor: 17.425

Review 8.  Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization.

Authors:  O Matsui; M Kadoya; J Yoshikawa; T Gabata; K Arai; H Demachi; S Miyayama; T Takashima; M Unoura; K Kogayashi
Journal:  Radiology       Date:  1993-07       Impact factor: 11.105

9.  Progression to hypervascular hepatocellular carcinoma: correlation with intranodular blood supply evaluated with CT during intraarterial injection of contrast material.

Authors:  Makiko Hayashi; Osamu Matsui; Kazuhiko Ueda; Yasuhiro Kawamori; Toshifumi Gabata; Masumi Kadoya
Journal:  Radiology       Date:  2002-10       Impact factor: 11.105

10.  Detection of hepatocellular carcinoma by CT during arterial portography using a cone-beam CT technology: comparison with conventional CTAP.

Authors:  Shiro Miyayama; Osamu Matsui; Masashi Yamashiro; Yasuji Ryu; Harumi Takata; Taro Takeda; Hiroyuki Aburano; Noriaki Shigenari
Journal:  Abdom Imaging       Date:  2009-07
View more
  6 in total

1.  Hemodynamics and progression of a hypervascular focus in a borderline lesion of hepatocellular carcinoma: analysis by angiography-assisted CT and histopathology.

Authors:  Tamao Endo; Kazuto Kozaka; Satoshi Kobayashi; Junichiro Sanada; Wataru Koda; Tetsuya Minami; Azusa Kitao; Norihide Yoneda; Yasuni Nakanuma; Toshifumi Gabata; Osamu Matsui
Journal:  Jpn J Radiol       Date:  2013-12-12       Impact factor: 2.374

Review 2.  Transarterial chemoembolization for hepatocellular carcinoma: A review of techniques.

Authors:  Norihiro Imai; Masatoshi Ishigami; Yoji Ishizu; Teiji Kuzuya; Takashi Honda; Kazuhiko Hayashi; Yoshiki Hirooka; Hidemi Goto
Journal:  World J Hepatol       Date:  2014-12-27

3.  Efficacy of Superselective Conventional Transarterial Chemoembolization Using Guidance Software for Hepatocellular Carcinoma within Three Lesions Smaller Than 3 cm.

Authors:  Shiro Miyayama; Masashi Yamashiro; Rie Ikeda; Junichi Matsumoto; Kiyotaka Takeuchi; Naoko Sakuragawa; Teruyuki Ueda; Taku Sanada; Kazuo Notsumata; Takuro Terada
Journal:  Cancers (Basel)       Date:  2021-12-19       Impact factor: 6.639

4.  Does Establishing a Safety Margin Reduce Local Recurrence in Subsegmental Transarterial Chemoembolization for Small Nodular Hepatocellular Carcinomas?

Authors:  Hyo-Jin Kang; Young Il Kim; Hyo-Cheol Kim; Hwan Jun Jae; Saebeom Hur; Jin Wook Chung
Journal:  Korean J Radiol       Date:  2015-08-21       Impact factor: 3.500

Review 5.  Ultraselective conventional transarterial chemoembolization: When and how?

Authors:  Shiro Miyayama
Journal:  Clin Mol Hepatol       Date:  2019-04-26

6.  Prognostic role of multiparameter MRI and radiomics in progression of advanced unresectable hepatocellular carcinoma following combined transcatheter arterial chemoembolization and lenvatinib therapy.

Authors:  Junpeng Luo; Zhimei Huang; Murong Wang; Tian Li; Jinhua Huang
Journal:  BMC Gastroenterol       Date:  2022-03-08       Impact factor: 3.067

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.